Events Calendar

NOTE: This is event is being held virtually. To attend via Zoom, registration is required. Please visit this link to register and attend: cancer.ucla.edu/JCCCSeminarSeries.

Presented by
David Ulmert, PhD
Assistant Professor in Residence, Department of Molecular and Medical Pharmacology
Director, UCLA Preclinical Theranostics Program

Dr. Hans David Ulmert's clinical research is focused on the study of risk factors and biomarkers related to clinically diagnosed prostate cancer and definitive end-points in non-screened cohorts. The findings of these studies extend into his translational research, which centers on development of novel in vivo strategies targeting enzymes regulated by the molecular pathways that drive the disease. His overarching goal is to apply these specific tissue-targeting vehicles for multimodal molecular imaging strategies, as well as for carriers of therapeutic agents.

Sponsored by the UCLA Jonsson Comprehensive Cancer Center Cancer Molecular Imaging, Nanotechnology & Theranostics research program.